Yvan is an accomplished senior executive with a track record of building transformational business success in the diagnostic and pharmaceutical industry since 1992.
Yvan joined Neopharm Labs in July 2021 following his most recent role as Director General of Dynacare Genetics and Specialty Service. During that time, Yvan was awarded the LabCorp Chairman Award in 2015 for his work in the areas of scientific leadership, customer focus, and for being the primary driver in building leading national laboratory testing business. Most recently, he was also selected for the Hero Award to recognize his extraordinary performance in support of the Covid-19 response.
Previous to Dynacare, Yvan was VP, Research & Development and General Manager of Warnex for eight years and also led the R&D department at Biochem for seven years before.
Yvan holds a Ph.D. in Biotechnology from the University of Sherbrooke, and has extensive industry knowledge around topics of life sciences, clinical development, medical devices, pharmaceuticals, infectious diseases as well as microbiology and immunology.
We are excited to have Yvan as President and General Director as he leads the Neopharm Labs, and our sister Company Averica Discovery, into the future with success.
If Yvan is ever out of his office, he is most likely at David’s Teas choosing his next flavour of his favourite hot beverage.